Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia.
Orlando G, Tariciotti L, Manzia TM, Gravante G, Sorge R, Manuelli M, Pisani F, Di Cocco P, Scelzo C, Burke GM, Soker S, Baiocchi L, Lerut J, Angelico M, Tisone G.
Orlando G, et al. Among authors: manuelli m.
Transpl Infect Dis. 2010 Feb;12(1):11-5. doi: 10.1111/j.1399-3062.2009.00449.x. Epub 2009 Sep 9.
Transpl Infect Dis. 2010.
PMID: 19744283
Clinical Trial.